The European Commission actively supports research in the health sector, with the ultimate goal of achieving better health for everyone. Between 2007 and 2013, funding was granted under theEU Seventh Framework Programme for Research and Technological Development (FP7, 2007–13) and is currently continued under Horizon 2020(H2020, 2014–20). Projects funded by the European Commissioncover different areas of frontier and collaborative research. The main topics supported, ranked by funding received, have been brain disorders, cancer, cardiovascular diseases, diabetes, obesity, and other chronic diseases. Within FP7, the funding for other chronic diseases focused on non-lethal diseases with a large impact on quality of life at old age, and on translational projects.1 Within H2020, the allocated budget has shifted towards societal challenges and includes broader topics. We aimed to assess research funding for common digestive diseases within FP7 and H2020, and put this into perspective with regard to disease prevalence and the burden of these diseases in terms of total health-care need and quality of life. We examined project abstracts in the European Commission database published between 2007 and 2017, to identify projects relating to gastrointestinal diseases.
Funding for gastrointestinal disease research in the European Union / Törnblom, Hans; Simrén, Magnus; Barbara, Giovanni; Niesler, Beate. - In: THE LANCET. GASTROENTEROLOGY & HEPATOLOGY. - ISSN 2468-1253. - STAMPA. - 3:9(2018), pp. 593-595. [10.1016/S2468-1253(18)30203-6]
Funding for gastrointestinal disease research in the European Union
Barbara, Giovanni;
2018
Abstract
The European Commission actively supports research in the health sector, with the ultimate goal of achieving better health for everyone. Between 2007 and 2013, funding was granted under theEU Seventh Framework Programme for Research and Technological Development (FP7, 2007–13) and is currently continued under Horizon 2020(H2020, 2014–20). Projects funded by the European Commissioncover different areas of frontier and collaborative research. The main topics supported, ranked by funding received, have been brain disorders, cancer, cardiovascular diseases, diabetes, obesity, and other chronic diseases. Within FP7, the funding for other chronic diseases focused on non-lethal diseases with a large impact on quality of life at old age, and on translational projects.1 Within H2020, the allocated budget has shifted towards societal challenges and includes broader topics. We aimed to assess research funding for common digestive diseases within FP7 and H2020, and put this into perspective with regard to disease prevalence and the burden of these diseases in terms of total health-care need and quality of life. We examined project abstracts in the European Commission database published between 2007 and 2017, to identify projects relating to gastrointestinal diseases.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
